![]() |
|
|
College of Pharmacy, Previous studies have shown that radiation in combination with oltipraz
enhances hepatic microsomal epoxide hydrolase expression. The effects
of
-ray radiation exposure in combination with oltipraz on the
expression of hepatic glutathione-S-transferase (GST)
subunits Ya, Yb1, Yb2,
Yc1, and Yc2 were examined in the rat.
Northern RNA blot analyses revealed that GST mRNA levels were altered
in response to daily 3- or 0.5-Gy doses of radiation. The hepatic GST
mRNA levels were transiently decreased at 3 and 8 hr after a single
3-Gy dose of radiation. The GST Ya, Yb1, Yb2, Yc1, and Yc2 mRNA levels
were increased by 2-4-fold at 15 and 24 hr after irradiation with 3 Gy, followed by return to the levels of untreated rats at 48 hr after
treatment. The treatment of animals with oltipraz alone resulted in
dose-related increases in the GST Ya, Yb1, Yc1, and Yc2 mRNA levels,
whereas Yb2 mRNA levels were minimally increased. Although a single
dose of oltipraz (30 mg/kg orally) caused a minimal 2-fold elevation in
the hepatic GST Ya mRNA level, exposure of animals to both oltipraz and
3-Gy radiation resulted in a 4-fold relative increase in GST Ya mRNA
level, indicating that the Ya mRNA expression was additively enhanced
by the combination treatment. The Yb1/2 and Yc1/2 mRNA expressions were
also enhanced by oltipraz in combination with radiation. Multiple
exposure of rats to daily 0.5-Gy radiation caused time-related
increases in GST gene expression. The greatest enhancement in GST
expression was observed at 24 hr after a single 0.5-Gy dose of
radiation in conjunction with oltipraz (e.g., a 9-fold relative
increase in GST Ya), whereas the relative additive
increases in GST mRNA were less pronounced at day 3 or 5 after
treatment. These increases in the GST mRNA levels were consistent with
those in the immunochemically detectable GST protein levels.
Histopathological examinations revealed that exposure of rats to
radiation (0.5 Gy/day for 3-5 days) caused mild-to-moderate hepatocyte
degeneration with sinusoidal congestion, whereas oltipraz (30 mg/kg/day
for 3 days) was effective in blocking the radiation-induced liver
injury. The enhanced expression of these GST isoforms by oltipraz may
be associated in part with its hepatoprotective effect against the
injury caused by ionizing radiation.
Copyright © by The American Society for Pharmacology and Experimental Therapeutics
This article has been cited by other articles:
![]() |
J. Y. Lee, C. Y. Han, J. W. Yang, C. Smith, S. K. Kim, E. Y.-H. P. Lee, S. G. Kim, and K. W. Kang Induction of Glutathione Transferase in Insulin-Like Growth Factor Type I Receptor-Overexpressed Hepatoma Cells Mol. Pharmacol., October 1, 2007; 72(4): 1082 - 1093. [Abstract] [Full Text] [PDF] |
||||
![]() |
I-N. Park, I. J. Cho, and S. G. Kim Ceramide Negatively Regulates Glutathione S-transferase Gene Transactivation via Repression of Hepatic Nuclear Factor-1 That Is Degraded by the Ubiquitin Proteasome System Mol. Pharmacol., June 1, 2004; 65(6): 1475 - 1484. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Y. Park, I. J. Cho, and S. G. Kim Transactivation of the PPAR-Responsive Enhancer Module in Chemopreventive Glutathione S-Transferase Gene by the Peroxisome Proliferator-Activated Receptor-{gamma} and Retinoid X Receptor Heterodimer Cancer Res., May 15, 2004; 64(10): 3701 - 3713. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zsivkovits, K. Fekadu, G. Sontag, U. Nabinger, W. W. Huber, M. Kundi, A. Chakraborty, H. Foissy, and S. Knasmuller Prevention of heterocyclic amine-induced DNA damage in colon and liver of rats by different lactobacillus strains Carcinogenesis, December 1, 2003; 24(12): 1913 - 1918. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Kang, S. Y. Choi, M. K. Cho, C. H. Lee, and S. G. Kim Thrombin Induces Nitric-oxide Synthase via Galpha 12/13-coupled Protein Kinase C-dependent I-kappa Balpha Phosphorylation and JNK-mediated I-kappa Balpha Degradation J. Biol. Chem., May 2, 2003; 278(19): 17368 - 17378. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Kang, E. Y. Park, and S. G. Kim Activation of CCAAT/enhancer-binding protein {beta} by 2'-amino-3'-methoxyflavone (PD98059) leads to the induction of glutathione S-transferase A2 Carcinogenesis, March 1, 2003; 24(3): 475 - 482. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Kang, I. J. Cho, C. H. Lee, and S. G. Kim Essential Role of Phosphatidylinositol 3-Kinase-Dependent CCAAT/Enhancer Binding Protein {beta} Activation in the Induction of Glutathione S-Transferase by Oltipraz J Natl Cancer Inst, January 1, 2003; 95(1): 53 - 66. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Kang, S. J. Lee, J. W. Park, and S. G. Kim Phosphatidylinositol 3-Kinase Regulates Nuclear Translocation of NF-E2-Related Factor 2 through Actin Rearrangement in Response to Oxidative Stress Mol. Pharmacol., November 1, 2002; 62(5): 1001 - 1010. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Kang, M. K. Cho, C. H. Lee, and S. G. Kim Activation of Phosphatidylinositol 3-Kinase and Akt by tert-Butylhydroquinone Is Responsible for Antioxidant Response Element-Mediated rGSTA2 Induction in H4IIE Cells Mol. Pharmacol., April 16, 2001; 59(5): 1147 - 1156. [Abstract] [Full Text] |
||||
![]() |
K. W. Kang, J. H. Ryu, and S. G. Kim The Essential Role of Phosphatidylinositol 3-Kinase and of p38 Mitogen-Activated Protein Kinase Activation in the Antioxidant Response Element-Mediated rGSTA2 Induction by Decreased Glutathione in H4IIE Hepatoma Cells Mol. Pharmacol., November 1, 2000; 58(5): 1017 - 1025. [Abstract] [Full Text] |
||||
![]() |
S. G. Kim, M. K. Cho, S. H. Choi, H. J. Kim, M. K. Kwak, and N. D. Kim Molecular Basis for Hepatic Detoxifying Enzyme Induction by 2-(Allylthio)pyrazine in Rats in Comparison with Oltipraz: Effects on Prooxidant Production and DNA Degradation Drug Metab. Dispos., June 1, 1999; 27(6): 667 - 673. [Abstract] [Full Text] |
||||
![]() |
S. G. Kim, J. Y. Cho, Y. S. Chung, E-T. Ahn, K.-Y. Lee, and Y.-B. Han Suppression of Xenobiotic-Metabolizing Enzyme Expression in Rats by Acriflavine, a Protein Kinase C Inhibitor. Effects on Epoxide Hydrolase, Glutathione S-Transferases, and Cytochromes P450 Drug Metab. Dispos., January 1, 1998; 26(1): 66 - 72. [Abstract] [Full Text] |
||||